Dow Up 0.92% Nasdaq Up 1.15%

More On QRXPY

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

QRxPharma Limited (QRXPY)

-Other OTC
0.07 0.00(0.00%) Oct 29
Prev Close:0.07
Open:0.07
Bid:N/A
Ask:N/A
1y Target Est:5.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.06 - 4.35
Volume:0
Avg Vol (3m):8,220
Market Cap:2.30M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-11) :N/A
Quarterly EPS Est (Dec-08) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

QRxPharma Limited develops and commercializes biopharmaceutical products primarily in Australia. It develops proprietary Dual Opioid formulations for treating patients with moderate to severe acute or chronic pain. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback